Skip to main content
Article
An Unexpected Finding of Hepatosplenomegaly in a Pediatric Patient
Clinical Pediatrics
  • Hailey C. Barootes, Western University
  • Chitra Prasad, Western University
  • C. Anthony Rupar, Western University
  • Dhandapani Ashok, Western University
Document Type
Article
Publication Date
1-1-2022
URL with Digital Object Identifier
10.1177/00099228211059668
Abstract

Gaucher disease (GD) is a rare autosomal recessive metabolic disorder. It is characterized by a deficiency of lysosomal glucocerebrosidase, which results in the accumulation of glycosphingolipid substrates, primarily glucosylceramide, in the phagocyte system. In GD Type 1, the liver, spleen, and bone marrow are typically affected. We report the case of a 7-year-old female with GD Type 1 who presented with hepatosplenomegaly detected incidentally following a motor vehicle accident. She was found to have concomitant thrombocytopenia and Erlenmeyer flask deformities of her lower limbs. Diagnosis was made on the basis of very low leukocyte β-glucocerebrosidase activity and elevated plasma chitotriosidase. DNA mutation studies revealed both c.1226A>G and c.116_1505 deletion (exons 3-11). The patient is currently managed with biweekly intravenous imiglucerase (Cerezyme) replacement therapy. She demonstrated resolution of thrombocytopenia and hepatosplenomegaly at 2-year follow-up. Physicians must consider this rare diagnosis in children presenting with hepatosplenomegaly to prompt timely management.

Citation Information
Hailey C. Barootes, Chitra Prasad, C. Anthony Rupar and Dhandapani Ashok. "An Unexpected Finding of Hepatosplenomegaly in a Pediatric Patient" Clinical Pediatrics Vol. 61 Iss. 1 (2022) p. 81 - 85
Available at: http://works.bepress.com/dhandapani-ashok/8/